|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM159864836 |
003 |
DE-627 |
005 |
20250207000330.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0533.xml
|
035 |
|
|
|a (DE-627)NLM159864836
|
035 |
|
|
|a (NLM)16386957
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Gallot, Géraldine
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection
|b a case study
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 17.04.2006
|
500 |
|
|
|a Date Revised 10.12.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a In a patient with chronic active Epstein-Barr virus infection associated with vasculitis and fulminant CD4+ T cell lymphoproliferative disorder, we probed the peripheral blood mononuclear cells (PBMC) for the presence of an EBV-specific T cell repertoire and tested the possible relationship between the lymphocytic infiltrate and the EBV-specific T cell response. Our results give credence to the presence of an apparently normal EBV-specific memory T cell response after in vitro reactivation of the patient's PBMC with autologous infected B lymphoblastoid cell lines. In keeping with the characterization of the vasculitis, certain T cell subsets were detected after expansion of skin lesion-infiltrating lymphocytes and were found to be infected with EBV. These particular T cell expansions were neither the effectors nor the targets of the in vitro reactivated EBV-specific T cells, thus excluding a simple relationship between EBV, the skin lesions, and the T cell expansions frequently observed in these patients
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Complementarity Determining Regions
|2 NLM
|
650 |
|
7 |
|a DNA, Viral
|2 NLM
|
650 |
|
7 |
|a Epitopes, T-Lymphocyte
|2 NLM
|
650 |
|
7 |
|a Peptide Fragments
|2 NLM
|
650 |
|
7 |
|a Receptors, Antigen, T-Cell, alpha-beta
|2 NLM
|
650 |
|
7 |
|a Tumor Necrosis Factor-alpha
|2 NLM
|
650 |
|
7 |
|a Viral Proteins
|2 NLM
|
700 |
1 |
|
|a Hamidou, Mohamed A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Clémenceau, Béatrice
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gaschet, Joëlle
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tiberghien, Pierre
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ferrand, Christophe
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vivien, Régine
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Barbarot, Sébastien
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Coste-Burel, Marianne
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Moreau, Anne
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vié, Henri
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 119(2006), 1 vom: 15. Apr., Seite 79-86
|w (DE-627)NLM098196855
|x 1521-6616
|7 nnns
|
773 |
1 |
8 |
|g volume:119
|g year:2006
|g number:1
|g day:15
|g month:04
|g pages:79-86
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 119
|j 2006
|e 1
|b 15
|c 04
|h 79-86
|